775d Ustekinumab Versus Adalimumab for Induction and Maintenance Therapy in Moderate-to-Severe Crohn’s Disease: The SEAVUE Study
暂无分享，去创建一个
S. Hanauer | B. Sands | J. Lewis | W. Sandborn | E. Loftus | R. Panaccione | S. Danese | M. Allez | V. Jairath | P. Irving | E. Scherl | A. Greenspan | C. Gasink | E. Mihály | T. Kuehbacher | T. Hoops | J. Izanec | Long-Long Gao | O. Shchukina